Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julia Abugova"'
Autor:
Alexander Karelin, Julia Abugova, G.A. Novichkova, Gusel Scharapova, Konstantin Kondratchik, Arend von Stackelberg, Alexander Karachunskiy, Lebedev Vv, Natalia Judina, Oleg Bydanov, N.V. Myakova, T. V. Nasedkina, Natalia Korepanova, Julia Roumiantseva, Almira Chervova, Dmitry Litvinov, Sergei O. Kuznetsov, Natalia Ponomareva, Olga V. Ryskal, O. R. Arakaev, Svetlana Lagoiko, Lyudmila Bajdun, Irina Spichak, Joachim Boos, Alexander Rumjanzew, Günter Henze, Larisa Fechina, Gesche Tallen, Evgeniya Inyushkina, Marina Goroshkova, Alexander Shapochnik, Shamardina Av, Olga V. Aleinikova
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Favorable outcomes were achieved for children with acute lymphoblastic leukemia (ALL) with the first Russian multicenter trial Moscow–Berlin (ALL-MB) 91. One major component of this regimen included a total of 18 doses of weekly intramuscul
Autor:
Larisa Shelikhova, Olga Molostova, Arina Rakhteenko, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Yakov Muzalevsky, Alexey Kazachenok, Dmitry Pershin, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 138:1736-1736
Introduction Autologous chimeric antigen receptor (CAR) T cells induce high rate of deep remissions among children with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL). In a significant proportion of patients true cure is ach
Autor:
Olga Molostova, Larisa Shelikhova, Yakov Muzalevsky, Alexey Kazachenok, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Pavel Trakhtman, Dmitry Pershin, Viktoria Zubachenko, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 138:1737-1737
Introduction CD19 CAR-T is a highly effective therapy among children with relapsed/refractory B-ALL. The optimal approach to delivery of this therapy and the best post-remission strategy remain to be established. We have tested in a prospective acade
Autor:
Irina Shipitsina, Daria Kobyzeva, Maria Ilushina, Alexander Popov, Julia Abugova, Elena Kurnikova, Ekaterina Mikhailova, Yulia Olshanskaya, Larisa Shelikhova, Maria Fadeeva, Michael Maschan, Dmitriy Balashov, Alexey Maschan, Anna Bogoyavlenskaya, Zhanna Shekhovtsova, Alexey Nechesnyuk, Daria Shasheleva, Rimma Khismatullina, Alexey Kazachenok, Sergey Blagov, Natalia Miakova, Dmitriy Pershin, Yakov Muzalevsky, Galina Novichkova, Dmitry Litvinov
Publikováno v:
Blood. 134:4618-4618
Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is indicated for patients with relapsed or refractory acute lymphoblastic leukemia. Patients with persistence of minimal residual disease (MRD) before HCT are at increased risk of
Autor:
Karachunskiy, Alexander, Tallen, Gesche, Roumiantseva, Julia, Lagoiko, Svetlana, Chervova, Almira, von Stackelberg, Arend, Aleinikova, Olga, Bydanov, Oleg, Bajdun, Lyudmila, Nasedkina, Tatiana, Korepanova, Natalia, Kuznetsov, Sergei, Novichkova, Galina, Goroshkova, Marina, Litvinov, Dmitry, Myakova, Natalia, Ponomareva, Natalia, Inyushkina, Evgeniya, Kondratchik, Konstantin, Abugova, Julia
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Apr2019, Vol. 145 Issue 4, p1001-1012, 12p